ColleenCatherineMcCormickMD

Obstetrics & Gynecology • Baltimore, MD

Gynecologic Oncology

Physician

Join to view full profile

Dr. McCormick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McCormick's full profile

Already have an account?

Office
4940 Eastern Ave
Baltimore, MD 21224
Phone+1 410-550-5568

Fax+1 503-413-8655

Education & Training

Johns Hopkins UniversityFellowship, Gynecologic Oncology, 2009
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2002 - 2006
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2001 - 2002
Johns Hopkins University School of MedicineClass of 2001

Certifications & Licensure

MD State Medical License 2006 - 2025
NM State Medical License 2021 - 2025
OR State Medical License 2009 - 2025
WA State Medical License 2009 - 2022
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall surviv...
Ying L Liu, Cara A Mathews, Fiona Simpkins, Karen A Cadoo, Diane Provencher
Cancer. 2025-01-15
2 citations
Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An a...
Mitchell R Kamrava, Antonio Gonzalez-Martin, Bhavana Pothuri, Ignace Vergote, Whitney Graybill
Gynecologic Oncology. 2024-10-01
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, Whitney S Graybill, Ana Beatriz Sánchez
Gynecologic Oncology. 2024-08-01

Press Mentions

School Nurse Returns to ICU After ClosuresApril 29th, 2020
Legacy Salmon Creek Study Featured in Medical JournalOctober 22nd, 2019
Legacy Participates in Trial for Promising Ovarian Cancer Drug - Portland Business JournalOctober 2nd, 2019